NCT04630964 The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density Status COMPLETED Phase PHASE2
NCT04620759 Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04593563 The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder Status UNKNOWN Phase PHASE2
NCT04522804 Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer Status COMPLETED Phase EARLY_PHASE1
NCT04505189 Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study Status COMPLETED Phase PHASE1/PHASE2
NCT04433858 An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04433845 The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. Status UNKNOWN Phase PHASE2
NCT04424225 Visual Surround Suppression and Perceptual Expectation Under Psilocybin Status TERMINATED Phase PHASE1
NCT04280055 Prophylactic Effects of Psilocybin on Chronic Cluster Headache Status TERMINATED Phase PHASE1/PHASE2
NCT04141501 Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients Status COMPLETED Phase PHASE2
NCT04123314 Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease Status RECRUITING Phase EARLY_PHASE1
NCT03775200 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT03604744 Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin Status COMPLETED Phase EARLY_PHASE1